ALFA Finder| Revenue growth | 162% YoY to ₹314 crore in Q4FY26. |
|---|---|
| Margins | Targeting blended EBITDA margins of 18-20%. |
| Order book | Described as 'too strong enough even to comment right now'. |
| Demand visibility | Strong traction in US oilfield chemicals and recovery in apparel exports. |
| Management confidence | High, revised $200M CCT revenue target timeline from 2030 to 2028. |
Growth
Revenue surged 162% YoY; PAT grew 118% to ₹44cr. International revenue rose to 70%.
Outlook
Targeting $200M revenue from CCT by FY28 (revised from 2030); consolidated EBITDA margins projected at 18-20%.
Risks
Global logistics volatility, container shortages, and raw material supply chain tightness were noted as recent challenges.
Earnings Call filed with BSE, NSE: FCL. Summary written with AI assistance from the document.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹51.50
- Market cap
- ₹5,997 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 49.0×Sector 35.5×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 2.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Board Meeting Date
Fineotex Chemical Ltd has scheduled a board meeting on November 13, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.